Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
基本信息
- 批准号:7892114
- 负责人:
- 金额:$ 8.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This renewal application requests continuing support for the Molecular and Cellular Pharmacology Predoctoral Training (MCP) Program at the University of Wisconsin-Madison. Graduate training in pharmacology has been strong at Wisconsin for many decades and is distributed among a number of departments and colleges. In 1994, the Pharmacology training faculty at Wisconsin joined together under the auspices of the Molecular and Cellular Pharmacology Program. This has created a campus-wide nucleus of faculty who are highly interactive scientifically and share an interest in training modern pharmacologists. The Molecular and Cellular Pharmacology Program has been strongly supported across campus. This initiative ahs revitalized the campus-wide Pharmacology curriculum, seminar series, and has sparked innumerable interdepartmental research and training activities that have enriched the environment for modern Pharmacology training. These changes have been very attractive to students with an interest in molecular and cellular pharmacology, and this has resulted in the recruiting and training of an outstanding cohort of young scientists to the Graduate Program. To fully take advantage of this superior training environment, this proposal is requesting continuing funds for the training of predoctoral students, starting with an increase of to 12 starting with year 10. The Program is designed to provide graduate students with interdisciplinary and integrated training in fundamental concepts in modern pharmacology with an emphasis on biochemical, molecular and cellular approaches with clear applications to human health. The didactic curriculum provides a solid base in all of these disciplines and is built on a strong foundation of rigorous in depth research training in modern pharmacology. Although the training emphasizes a research career, the training experience is designed to develop leadership and teaching abilities as well. All of the preceptors have peer-reviewed, active, and aggressive research programs that offer training opportunities in most areas of molecular and cellular pharmacology. With continued NIH support, the MCP Program will continue to enhance its tradition of providing the U.S. biomedical and pharmacological communities with expertly trained research scientists. These scientists are the future of biomedical research in Pharmacology.
描述(由申请人提供):此更新申请要求继续支持威斯康星大学麦迪逊分校的分子和细胞药理学博士前培训(MCP)计划。药理学研究生培训在威斯康星州已经强大了几十年,分布在一些部门和学院。1994年,威斯康星州的药理学培训学院在分子和细胞药理学项目的主持下联合起来。这创造了一个校园范围内的教师核心,他们在科学上高度互动,并对培养现代药理学家感兴趣。分子和细胞药理学计划得到了校园的大力支持。这一举措ahs振兴了校园范围内的药理学课程,研讨会系列,并引发了无数的跨部门的研究和培训活动,丰富了现代药理学培训的环境。这些变化对对分子和细胞药理学感兴趣的学生非常有吸引力,这导致了一批优秀的年轻科学家的招募和培训。为了充分利用这一上级培训环境,该提案要求继续提供资金,用于培训博士预科生,从第10年开始增加到12名。该计划旨在为研究生提供现代药理学基本概念的跨学科和综合培训,重点是生物化学,分子和细胞方法,并明确应用于人类健康。教学课程提供了所有这些学科的坚实基础,并建立在现代药理学严格的深入研究培训的坚实基础上。虽然培训强调研究生涯,但培训经验也旨在培养领导能力和教学能力。所有的导师都有同行评审,积极和积极的研究计划,在分子和细胞药理学的大多数领域提供培训机会。在NIH的持续支持下,MCP计划将继续加强其为美国生物医学和药理学社区提供训练有素的研究科学家的传统。这些科学家是药理学生物医学研究的未来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard A. Anderson其他文献
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton.
蛋白质 4.1 和带 3 之间的相互作用。膜骨架元件的替代结合位点。
- DOI:
- 发表时间:
1985 - 期刊:
- 影响因子:4.8
- 作者:
Gary R. PasternackS;Richard A. Anderson;Thomas L. Leto;Vincent T. Marchesi - 通讯作者:
Vincent T. Marchesi
Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
性腺功能减退男性中合成雄激素 7 α-甲基-19-去甲睾酮的组织选择性的证据。
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:5.8
- 作者:
Richard A. Anderson;A. Michael Wallace;N. Sattar;Narendar Kumar;K. Sundaram - 通讯作者:
K. Sundaram
FROM THIENOPYRIDINES TO NITROSOTHIOLS: A NOVEL POTENTIAL MECHANISM OF THIENOPYRIDINES BIOACTIVITY
- DOI:
10.1016/s0735-1097(11)61918-9 - 发表时间:
2011-04-05 - 期刊:
- 影响因子:
- 作者:
Richard A. Anderson;Shantu Bundhoo;Ewelina Sagan;Jessica Dada;Rebecca Harris;Phillip James - 通讯作者:
Phillip James
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
在临床试验中测量卵巢毒性:美国临床肿瘤学会研究声明。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
W. Cui;R. Rocconi;Ramya Thota;Richard A. Anderson;S. Bruinooge;Ioanna A Comstock;N. Denduluri;Audrey Gassman;Julie R Gralow;Karla J. Hutt;L. Amiri;M. Lambertini;John K Leighton;Karen H Lu;S. Mostoufi;Teri Pollastro;Shan Pradhan;H. Saber;Caroline Schenkel;D. Spratt;S. Wedam;K. Phillips - 通讯作者:
K. Phillips
Explorer Identification of the niche and phenotype of the first human hematopoietic stem cells
Explorer 鉴定第一个人类造血干细胞的生态位和表型
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
A. Ivanovs;S. Rybtsov;Richard A. Anderson;Marc L. Turner;A. Medvinsky - 通讯作者:
A. Medvinsky
Richard A. Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard A. Anderson', 18)}}的其他基金
Tau-PI3Kalpha Complex in Regulation of PI3K/Akt-dependent Neuronal Function and Survival
Tau-PI3Kalpha 复合物调节 PI3K/Akt 依赖性神经元功能和存活
- 批准号:
10710161 - 财政年份:2022
- 资助金额:
$ 8.7万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10386086 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10323007 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10077869 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Administrative Supplement: Phosphoinositide Signaling in the Cytosol and Nucleus
行政补充:细胞质和细胞核中的磷酸肌醇信号传导
- 批准号:
10799130 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10561701 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:
9027153 - 财政年份:2015
- 资助金额:
$ 8.7万 - 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:
9199104 - 财政年份:2015
- 资助金额:
$ 8.7万 - 项目类别:
Phosphoinositide Signaling To and Within the Nucleus
进入细胞核和细胞核内的磷酸肌醇信号传导
- 批准号:
8059297 - 财政年份:2010
- 资助金额:
$ 8.7万 - 项目类别:
Phosphatidylinositol (PI) Signaling Role in Ephitelial / Mesenchymal Transition
磷脂酰肌醇 (PI) 在上皮/间质转化中的信号作用
- 批准号:
7393089 - 财政年份:2004
- 资助金额:
$ 8.7万 - 项目类别:
相似海外基金
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
10331450 - 财政年份:2022
- 资助金额:
$ 8.7万 - 项目类别:
Predoctoral Training Program in Molecular Pharmacology
分子药理学博士前培训项目
- 批准号:
10642662 - 财政年份:2022
- 资助金额:
$ 8.7万 - 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:
10175159 - 财政年份:2021
- 资助金额:
$ 8.7万 - 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:
10402849 - 财政年份:2021
- 资助金额:
$ 8.7万 - 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:
10612465 - 财政年份:2021
- 资助金额:
$ 8.7万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10197160 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:
Pharmacology and Molecular Sciences Training Program
药理学和分子科学培训计划
- 批准号:
10617205 - 财政年份:2020
- 资助金额:
$ 8.7万 - 项目类别:














{{item.name}}会员




